UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009122
Receipt number R000010562
Scientific Title Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells
Date of disclosure of the study information 2012/10/17
Last modified on 2016/12/03 09:25:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells

Acronym

Liver Regeneration Therapy by Autologous Adipose Tissue Derived Stromal Cells

Scientific Title

Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells

Scientific Title:Acronym

Liver Regeneration Therapy by Autologous Adipose Tissue Derived Stromal Cells

Region

Japan


Condition

Condition

Liver Cirrhosis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the safety of administration of autologous adipose tissue derived stromal cells

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

assessment of safety in the context of adverse events defined in the implementation protocol

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

intrahepatic arterial administration of autologous adipose tissue derived stromal cells (3.3 x 10^5 cells/Kg or 6.6 x 10^5 cells/Kg)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Criteria defined in the implementation protocol

Key exclusion criteria

Criteria defined in the implementation protocol

Target sample size

4


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shuichi Kaneko

Organization

Kanazawa University

Division name

Department of Gastroenterology

Zip code


Address

13-1 Takara-machi, Kanazawa, JAPAN

TEL

076-265-2000

Email

skaneko@m-kanazawa.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshio Sakai

Organization

Kanazawa University

Division name

Department of Gastroenterology

Zip code


Address

13-1 Takara-machi, Kanazawa, JAPAN

TEL

076-265-2235

Homepage URL


Email

yoshios@m-kanazawa.jp


Sponsor or person

Institute

Kanazawa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

NCT01062750

Org. issuing International ID_1

the U.S. National Institutes of Health

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢大学附属病院


Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 08 Month 28 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 17 Day

Last follow-up date

2015 Year 02 Month 25 Day

Date of closure to data entry

2015 Year 04 Month 22 Day

Date trial data considered complete

2015 Year 05 Month 07 Day

Date analysis concluded

2015 Year 05 Month 18 Day


Other

Other related information



Management information

Registered date

2012 Year 10 Month 16 Day

Last modified on

2016 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010562


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name